Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 97Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Follicular 81Lymphoma 62Lymphoma, Mantle-Cell 59Lymphoma, B-Cell, Marginal Zone 47Lymphoma, Non-Hodgkin 46Recurrence 35Lymphoma, B-Cell 24Leukemia 20Waldenstrom Macroglobulinemia 18Hodgkin Disease 18Lymphoma, T-Cell, Peripheral 16Burkitt Lymphoma 14Lymphoma, T-Cell, Cutaneous 12Lymphoma, T-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Sezary Syndrome 10Mycosis Fungoides 10Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 8Lymphoma, Large-Cell, Immunoblastic 7Intraocular Lymphoma 7Neoplasms 6Lymphoma, Extranodal NK-T-Cell 6Leukemia, B-Cell 6Leukemia, Hairy Cell 5Leukemia-Lymphoma, Adult T-Cell 4

Interventions

tofacitinib 7ofatumumab 4ibrutinib 4Rituximab 2KW-2478 2Dasatinib 2Alemtuzumab 2ziconotide 1sodium luminolate 1ruxolitinib 1oblimersen 1obinutuzumab 1mocetinostat 1milatuzumab 1ixekizumab 1fludarabine 1fenebrutinib 1baricitinib 1abexinostat 1Saline Solution 1Lenalidomide 1Hsp90 inhibitor KU757 1Etanercept 1Cyclophosphamide 1Bortezomib 1B3(Fv)-PE38KDEL recombinant immunotoxin 14-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchiolitis Obliterans Syndrome × Lenalidomide × Lymphoid × Clear all
NCT01600053 2016-12-15

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

University of California, San Diego

Phase 2 Terminated
11 enrolled 4 charts
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡